Biotech

All Articles

Kailera launches along with $400M series A, 4 Mandarin weight problems drugs

.Kailera Therapies has actually launched in to the progressively congested being overweight area alo...

Metsera teams up with Amneal to lock down GLP-1 supply

.With very early phase 1 data now out in the wild, metabolic ailment clothing Metsera is squandering...

Rivus posts records to support muscle-sparing weight problems drug insurance claims

.Rivus Pharmaceuticals has unveiled the records behind its phase 2 being overweight succeed in heart...

BMS pays $110M to develop T-cell treatment treaty, helping Top purchase opportunity to improve prioritized pipeline

.Bristol Myers Squibb is actually paying Prime Medication $110 million ahead of time to establish re...

Generate increases one more $1B-plus Big Pharma relationship

.Novartis has inked a deal potentially worth greater than $1 billion along with Flagship-founded Gen...

Metsera GLP-1 records slice shows 7.5% weight-loss at 36 days

.Lately debuted Metsera is actually unfolding some phase 1 information for its own GLP-1 receptor ag...

Flagship hopes biotechs group to Mirai to increase hereditary meds

.Amid the hereditary medications arms nationality, Main Pioneering is actually revealing a new busin...

BioAge eyes $180M from IPO, private placement for being overweight trials

.BioAge Labs is actually looking at about $180 thousand in first profits from an IPO and a personal ...

Merck's LAG-3 combo falls short colorectal cancer cells phase 3 research

.An attempt through Merck &amp Co. to open the microsatellite stable (MSS) metastatic intestines can...

Spanish VC closes $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has closed a fund of 180 million europeans ($ 200 million), amount of m...